[1] Anstrom K. J., Tsiatis A. A., Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data, Biometrics, 2002, 57(4):1207-1218.
[2] Bitouzé D., Laurent B., Massart P., A Dvoretzky-Kiefer-Wolfowitz type inequality for the Kaplan-Meier estimator, Ann. Inst. H. Poincare-probab. Staiost, 1999, 35(6):735-763.
[3] Breslow N. E., Chatterjee N., Design and analysis of two-phase studies with binary outcome applied to Wilms tumor prognosis, J. R. Stat. Soc. Ser. C Appl., 1999, 48(4):457-468.
[4] Cao Y. X., Yu J. C., Liu Y. Y., Optimal generalized case-cohort analysis with Cox's proportional hazards model, Acta Math. Appl. Sin. Engl. Ser., 2015, 31(3):841-867.
[5] Chen J. H., Rao J. N. K., Asymptotic normality under two-phase sampling designs, Stat. Sinica, 2007, 17(3):1047-1064.
[6] Deng L. F., Ding J. L., Liu Y. Y., et al., Regression analysis for the proportional hazards model with parameter constraints under case-cohort design, Comput. Stat. Data Anal., 2018, 117:194-206.
[7] Fleming T. R., Harrington D. P., Counting Processes and Survival Analysis, Wiley, New York, 1991.
[8] Ferguson T. S., A Course in Large Sample Theory, Chapman & Hall, Florida, 1996.
[9] Foutz R., On the unique consistent solution to the likelihood equations, J. Am. Stat. Assoc., 1977, 72(357):147-148.
[10] Gijsbers L., Ding E., Malik V., et al., Consumption of dairy foods and diabetes incidence:a dose-response meta-analysis of observational studies, Am. J. Clin. Nutr., 2016, 103(4):1111-1124.
[11] Gill R. D., Censoring and stochastic integrals, Stat. Neerl., 1980, 34(2):124-124.
[12] Green D. M., Breslow N. E., Beckwith J. B., et al., Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor:a report from the National Wilms' Tumor Study, J. Clin. Oncol., 1998, 16(1):237-245.
[13] Haneuse S., VanderWeele T., Arterburn D., Using the E-value to assess the potential effect of unmeasured confounding in observational studies, J. Am. Med. Assoc., 2019, 321(6):602-603.
[14] Hájek J., Limiting distributions in simple random sampling from a finite population, Publications of the Mathematical Institute of the Hungarian Academy of Sciences, 1960, 5:361-374.
[15] Holland P., Statistics and causal inference (with discussion), J. Am. Stat. Assoc., 1986, 81:945-970.
[16] Imbens G. W., Rubin D. B., Causal Inference for Statistics, Social, and Biomedical Sciences:An Introduction, Cambridge University Press, New York, 2015.
[17] Johnston S. C., Rootenberg J. D., Katrak S., et al., Effect of a US National Institutes of Health programme of clinical trials on public health and costs, Lancet, 2006, 367:1319-1327.
[18] Kulich M., Lin D. Y., Additive hazards regression for case-cohort studies, Biometrika, 2000, 87(1):73-87.
[19] Månsson R., Joffe M., Sun W. G., et al., On the estimation and use of propensity scores in case-control and case-cohort studies, Am. J. Epidemiol., 2007, 166(3):332-339.
[20] Mao H. Z., Li L., Yang W., et al., On the propensity score weighting analysis with survival outcome:Estimands, estimation, and inference, Stat. Med., 2018, 37(26):3745-3763.
[21] Neyman J., On the application of probability theory to agricultural experiments:Essay on principles, Section 9. Masters Thesis. Portions translated into english by D. Dabrowska and T. Speed (1990), Stat. Sci., 1990, 5(4):465-472.
[22] Peterson A., Expressing the Kaplan-Meier estimator as a function of empirical subsurvival functions, J. Am. Stat. Assoc., 1977, 72:854-858.
[23] Prentice R. L., A case-cohort design for epidemiologic cohort studies and disease prevention trials, Biometrika, 1986, 73(1):1-11.
[24] Robins J. M., Rotnitzky A., Recovery of information and adjustment for dependent censoring using surrogate markers, In:AIDS Epidemiology, Birkhauser, Boston, 1992.
[25] Rosenbaum P. R., Rubin D. B., The central role of the propensity score in observational studies for causal effects, Biometrika, 1983, 70(1):41-55.
[26] Rose, S. and van der Laan, M., A double robust approach to causal effects in case-control studies, Am. J. Epidemiol., 2014, 179(6):663-669.
[27] Rubin D. B., Estimating causal effects of treatments in randomized and nonrandomized studies, J. Educ. Psychol., 1974, 66(5):688-701.
[28] Rubin D. B., Inference and missing data, Biometrika, 1976, 63(3):581-592.
[29] Schuemie M., Hripcsak G., Ryan P., et al., Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data, P. Natl. Acad. Sci. USA, 2018, 115(11):2571-2577.
[30] VanderWeele T., Vansteelandt S., A weighting approach to causal effects and additive interaction in case-control studies:marginal structural linear odds models, Am. J. Epidemiol., 2011, 174(10):1197-1203.
[33] Wang J. G., A note on the uniform consistency of the Kaplan-Meier estimator, Ann. Stat., 1987, 15(3):1313-1316.
[32] Wang X., Beste L., Maierc M., et al., Double robust estimator of average causal treatment effect for censored medical cost data, Stat. Med., 2016, 35(18):3101-3116.
[33] Wang W. W., Scharfstein D., Tan Z. Q., et al., Causal inference in outcome-dependent two-phase sampling designs, J. Roy. Stat. Soc. B Stat. Methodol., 2009, 71(5):947-969.
[34] Yang S., Ding P., Asymptotic inference of causal effects with observational studies trimmed by the estimated propensity scores, Biometrika, 2018, 105(2):487-493.
[35] Yang S., Ding P., Combining multiple observational data sources to estimate causal effects, J. Am. Stat. Assoc., 2020, 115:1540-1554.
[36] Yu J. C., Shi Y. Y., Yang Q. L., et al., Additive hazards regression under generalized case-cohort sampling, Acta. Math. Sin. Engl. Ser., 2014, 30:251-260.